Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amber Hendrix

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Plos One|September 13, 2012
Metabolic rate regulates L1 longevity in C. elegansInhwan Lee, Amber Hendrix, Jeongho Kim, et al.
Journal for Immunotherapy of Cancer|February 28, 2025
T-cell immune checkpoint inhibition plus hypomethylation for locally advanced HER2-negative breast cancer: a phase 2 neoadjuvant window trial of decitabine and pembrolizumab followed by standard neoadjuvant chemotherapyHarry D Bear, Xiaoyan Deng, Dipankar Bandyopadhyay, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Plos One|September 13, 2012
Metabolic rate regulates L1 longevity in C. elegansInhwan Lee, Amber Hendrix, Jeongho Kim, et al.
Journal for Immunotherapy of Cancer|February 28, 2025
T-cell immune checkpoint inhibition plus hypomethylation for locally advanced HER2-negative breast cancer: a phase 2 neoadjuvant window trial of decitabine and pembrolizumab followed by standard neoadjuvant chemotherapyHarry D Bear, Xiaoyan Deng, Dipankar Bandyopadhyay, et al.
Pageof 1